Citations to this article
Citation Information: JCI Insight. 2020;5(8):e133754. https://doi.org/10.1172/jci.insight.133754.
Abstract
Atrial fibrillation (AF) alters atrial cardiomyocyte (ACM) Ca2+ handling, promoting ectopic beat formation. We examined the effects of AF-associated remodeling on Ca2+-related action potential dynamics and consequences for AF susceptibility. AF was maintained electrically in dogs by right atrial (RA) tachypacing. ACMs isolated from AF dogs showed increased Ca2+ release refractoriness, spontaneous Ca2+ spark frequency, and cycle length (CL) threshold for Ca2+ and action potential duration (APD) alternans versus controls. AF increased the in situ CL threshold for Ca2+/APD alternans and spatial dispersion in Ca2+ release recovery kinetics, leading to spatially discordant alternans associated with reentrant rotor formation and susceptibility to AF induction/maintenance. The clinically available agent dantrolene reduced Ca2+ leak and CL threshold for Ca2+/APD alternans in ACMs and AF dog right atrium, while suppressing AF susceptibility; caffeine increased Ca2+ leak and CL threshold for Ca2+/APD alternans in control dog ACMs and RA tissues. In vivo, the atrial repolarization alternans CL threshold was increased in AF versus control, as was AF vulnerability. Intravenous dantrolene restored repolarization alternans threshold and reduced AF vulnerability. Immunoblots showed reduced expression of total and phosphorylated ryanodine receptors and calsequestrin in AF and unchanged phospholamban/SERCA expression. Thus, along with promoting spontaneous ectopy, AF-induced Ca2+ handling abnormalities favor AF by enhancing vulnerability to repolarization alternans, promoting initiation and maintenance of reentrant activity; dantrolene provides a lead molecule to target this mechanism.
Authors
Tao Liu, Feng Xiong, Xiao-Yan Qi, Jiening Xiao, Louis Villeneuve, Issam Abu-Taha, Dobromir Dobrev, Congxin Huang, Stanley Nattel
Citations to this article in year 2023 (7)
| Title and authors | Publication | Year |
|---|---|---|
|
Cardiac Alternans: From Bedside to Bench and Back
Qu Z, Weiss JN |
Circulation research | 2023 |
|
Increased β1-adrenergic receptor antibody confers a vulnerable substrate for atrial fibrillation via mediating Ca2+ mishandling and atrial fibrosis in active immunization rabbit models
Sun H, Song J, Li K, Li Y, Shang L, Zhou Q, Lu Y, Zong Y, He X, Kari M, Yang H, Zhou X, Zhang L, Tang B |
Clinical science (London, England : 1979) | 2023 |
|
Targeted Atrial Fibrillation Therapy and Risk Stratification Using Atrial Alternans
Muthavarapu N, Mohan A, Manga S, Sharma P, Bhanushali AK, Yadav A, Damani DN, Jais P, Walton RD, Arunachalam SP, Kulkarni K |
Journal of Cardiovascular Development and Disease | 2023 |
|
Advances in basic and translational research in atrial fibrillation
Hu D, Barajas-Martinez H, Zhang ZH, Duan HY, Zhao QY, Bao MW, Du YM, Burashnikov A, Monasky MM, Pappone C, Huang CX, Antzelevitch C, Jiang H |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2023 |
|
RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease
Schmeckpeper J, Kim K, George SA, Blackwell D, Brennan JA, Efimov IR, Knollmann BC |
Journal of Molecular and Cellular Cardiology | 2023 |
|
Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts
Joshi P, Estes S, DeMazumder D, Knollmann BC, Dey S |
eLife | 2023 |
|
Personalized biomechanical insights in atrial fibrillation: opportunities & challenges.
Telle Å, Bargellini C, Chahine Y, Del Álamo JC, Akoum N, Boyle PM |
Expert Review of Cardiovascular Therapy | 2023 |
